Diagnostic performance of GENEDIA W and ActiveXpress+ COVID-19 antigens tests among symptomatic individuals in Peru and The United Kingdom.

Sandra Palomino-PadillaLorna FinchMargaretha de VosHelen R SavageLuz Villa-CastilloGail HaywardEloïse Cooknull nullnull nullnull nullCamille EscadafalRichard BodyEmily R AdamsCesar Ugarte-GilAna I Cubas-Atienzar

Published in: PloS one (2023)

Whilst the overall clinical sensitivity of the Genedia did not meet WHO minimum performance requirements for rapid immunoassays in either cohort, the ActiveXpress+ did so for the small UK cohort. This study illustrates comparative performance of Ag-RDTs across two global settings and considers the different approaches in evaluation methods.

Keyphrases

coronavirus disease
sars cov
cross sectional
dendritic cells
quantum dots
immune response
sensitive detection